Bad Returns for Biotech Probably Won’t Get Better Anytime Soon

(Bloomberg) -- Biotechnology’s underperformance to the broader market has only been this bad twice since the dot-com bubble, and Wall Street doesn’t see things getting better in the coming months e...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.